Atenção plena como opção terapêutica para as disfunções sexuais / Mindfulness as a therapeutic option for sexual dysfunctions

A prevalência das disfunções sexuais é alta na população geral. A capacidade de regular as experiências emocionais facilita o relacionamento mais adaptado aos estados internos e às condições ambientais. A prática da atenção plena promove atenção à experiência do momento presente ­ com curiosidade, abertura, aceitação, não reatividade e não julgamento ­ e tem se mostrado eficaz para melhorar muitas condições biopsicossociais, sendo utilizada em ambientes de saúde, escolas e locais de trabalho. O objetivo é apresentar atualizações na abordagem das dificuldades sexuais por meio do desenvolvimento da atenção plena. Entre outras recomendações, o treinamento para descentralizar a atenção, o desenvolvimento de habilidades para perceber pensamentos e sentimentos como estados mentais, não necessariamente reais, além de promover aceitação, compaixão e melhor gestão de pensamentos intrusivos e ruminativos são alguns pontos positivos da prática da atenção plena como única abordagem ou associada a outras. É apresentado um protocolo com grupo terapêutico para desenvolvimento da atenção plena para casais, em que o parceiro é sobrevivente do câncer de próstata. Segue uma proposta terapêutica com oito módulos desenvolvida em formato presencial e adaptada para a plataforma virtual. Os módulos são: definições e causas da disfunção sexual; conscientização crescente das sensações físicas; exploração do corpo e julgamentos sobre ele; consciência de pensamentos e crenças sexuais; trabalho com aversão e autotoque; consciência das sensações sexuais; foco sensorial com o parceiro; manutenção (e aumento) dos ganhos. Essa prática desenvolvida online abriu um campo importante para beneficiar portadores de disfunção sexual com dificuldade para buscar outras modalidades de intervenção.

Características clínico-patológicas de los pacientes asistidos en el Centro Docente Asociado de Oncología Médica en el Hospital Departamental de Soriano durante su primer año de funcionamiento / Clinical-pathological characteristics of patients assisted at the Associated Teaching Center of Medical Oncology at Soriano Departmental Hospital during its first year of operation / Características clínico-patológicas dos pacientes atendidos no Centro Docente Associado de Oncologia Médica no Hospital Departamental de Soriano durante seu primeiro ano de funcionamento

Introducción: Según el Ministerio de Salud las muertes por cáncer constituyen un cuarto del total de las defunciones registradas en Uruguay cada año. Objetivo: Conocer el perfíl epidemiológico de los pacientes diagnosticados de cáncer asistidos en el Hospital Departamental de Soriano. Material y métodos: Estudio observacional, retrospectivo y descriptivo que incluyó a los pacientes diagnosticados de cáncer asistidos en el Hospital Departamental de Soriano durante el 2022. Se mantuvo el anonimato de los pacientes en el análisis estadístico y se contó con la aprobación del Comité de Ética del Hospital de Clínicas. Resultados: Se incluyeron 113 pacientes nuevos; 53.1% fueron hombres, siendo la mediana de edad al diagnóstico de 69 años. Los 4 tumores más frecuentes para ambos sexos reunidos fueron: mama, próstata, pulmón y colo-recto; la distribución por estadio fue la siguiente: E IV 48.6% pacientes; EIII 22.5%; EII 26.5%; y EI 2.6%. En el 79.6% de las pacientes se contaba con la confirmación del diagnóstico mediante anatomía patológica. El tiempo entre el diagnóstico y el primer tratamiento oncológico fue ≤ 3 meses para el 88.2% de los pacientes. El total de los pacientes con EIV fueron contactados con la Unidad de Cuidados Paliativos. Únicamente el 15% de los casos fueron discutidos en Comité de Tumores. Conclusiones: Los datos analizados permitieron caracterizar el perfil epidemiológico del cáncer de los pacientes procedente de Soriano asistidos en el ámbito público y pueden contribuir a la implementación de políticas públicas orientadas a la prevención y por ende a la mejora en la asistencia pacientes asistidos.

Introduction: According to the Ministry of Health, cancer deaths constitute a quarter of the total deaths registered in Uruguay each year. Objective: To identify the epidemiological profile of patients diagnosed with cancer treated at the Departmental Hospital of Soriano. Materials and Methods: An observational, retrospective and descriptive study that included patients diagnosed with cancer attended at the Departmental Hospital of Soriano during 2022. The anonymity of the patients was maintained in the statistical analysis and approval was obtained from the Ethics Committee of the Hospital de Clínicas. Results: A total of 113 new patients were included; 53.1% were men, with a median age at diagnosis of 69 years old. The four most frequent tumors for both sexes were: breast, prostate, lung and colorectal; the distribution by stage was as follows: Stage IV 48.6% patients; Stage III 22.5%; Stage II 26.5%; and Stage I 2.6%. In 79.6% of the patients the diagnosis was confirmed by pathological anatomy. The time between diagnosis and first oncological treatment was ≤ 3 months for 88.2% of patients. The total number of patients with Stage IV were contacted by the Palliative Care Unit. Only 15% of the cases were discussed in the Tumor Committee. Conclusions: The data analyzed made it possible to characterize the epidemiological profile of cancer in patients from Soriano assisted in the public sector and may contribute to the implementation of public policies aimed at prevention and, therefore, at improving patient care.

Introdução: Segundo o Ministério da Saúde, as mortes por câncer constituem um quarto de todas as mortes registradas no Uruguai a cada ano. Objetivos: Conhecer o perfil epidemiológico dos pacientes diagnosticados com câncer atendidos no Hospital Departamental de Soriano. Material e Métodos: Estudo observacional, retrospectivo e descritivo que incluiu pacientes diagnosticados com câncer atendidos no Hospital Departamental de Soriano durante o ano de 2022. O anonimato dos pacientes foi mantido na análise estatística e foi aprovado pelo Comitê de Ética do Hospital de Clínicas. Resultados: foram incluídos 113 novos pacientes; 53,1% eram homens, com mediana de idade ao diagnóstico de 69 anos. Os 4 tumores mais frequentes para ambos os sexos combinados foram: mama, próstata, pulmão e colorretal; a distribuição por estágio foi a seguinte: E IV 48,6% pacientes; EIII 22,5%; EII 26,5%; EI 2,6%. Em 79,6% dos pacientes houve confirmação do diagnóstico pela patologia. O tempo entre o diagnóstico e o primeiro tratamento oncológico foi ≤ 3 meses para 88,2% dos pacientes. Todos os doentes com DIV foram contactados com a Unidade de Cuidados Paliativos. Apenas 15% dos casos foram discutidos no Comitê de Tumores. Conclusões: Os dados analisados ​​permitiram caracterizar o perfil epidemiológico do câncer em pacientes de Soriano atendidos na esfera pública e podem contribuir para a implementação de políticas públicas voltadas para a prevenção e, consequentemente, para a melhoria na assistência aos pacientes atendidos.

Tumor fibroso solitario de próstata: informe de caso y revisión de la literatura / Solitary fibrous tumor of the prostate: case report and literature review

El tumor fibroso solitario (TFS) es una neoplasia mesenquimatosa de tipo fibroblástico que, a pesar de ser localizado principalmente en pleura, se ha observado en otros órganos como la próstata. Por su parte, el tumor fibroso solitario de la próstata es una neoplasia de baja incidencia, crecimiento lento y potencial maligno incierto, que generalmente se compone de células fusiformes de apariencia citológicamente benignas, dispuestas en una arquitectura desorganizada, mezcladas con colágeno y pequeños vasos sanguíneos. Establecer su diagnóstico se ha vuelto más reproducible desde la identificación de la fusión de los genes NAB2-STAT6 por biología molecular, que lleva a la sobreexpresión de STAT6 por inmunohistoquímica, el cual es un marcador muy sensible y específico para TFS. Presentamos el caso clínico de un paciente que debutó con síntomas de compresión vesical, en quien se identificó una masa con epicentro en la próstata que infiltraba la vejiga y llegaba a la pared rectal, y que luego de estudios de patología, inmunohistoquímica y pruebas moleculares se clasificó como un TFS de la próstata, finalmente tratado con cistoprostatectomía radical más derivación urinaria

Solitary fibrous tumor (SFT) is a mesenchymal neoplasm of fibroblastic type, which despite being located mainly in the pleura, has been observed in other organs such as the prostate. On the other hand, solitary fibrous tumor of the prostate is a rare neoplasm, slow growing, and of uncertain malignant potential, which is generally composed of spindle cells of cytologically benign appearance, arranged in a disorganized architecture, mixed with collagen and small blood vessels. Establishing its diagnosis has become more reproducible since the identification of the NAB2-STAT6 gene fusion by molecular biology, leading to the overexpression of STAT6 by immunohistochemistry, a very sensitive and specific marker for SFT. We present a clinical report of a patient who consulted with symptoms of bladder compression, in whom a mass was identified with the epicenter in the prostate infiltrating into the bladder and reaching the rectal wall. Following histopathology study, immunohistochemistry and molecular tests it was classified as a SFT of the prostate, finally treated with radical cystoprostatectomy plus urinary shunt

Promoção à saúde em serviço de diabetes e hipertensão / Health promotion in diabetes and hypertension servisse / Promoción de la salud en el servicio de diabetes e hipertensión

Objetivo: descrever as atividades desenvolvidas, por um grupo tutorial do PET-SAÚDE, em um Centro Especializado do município de Feira de Santana, sobre a prevenção do câncer de mama e de próstata nos meses de Outubro e Novembro de 2022. Metodologia: As experiências foram baseadas em orientações e aconselhamentos verbais sobre a importância de hábitos de vida saudáveis, métodos de rastreio e diagnóstico precoce. Resultados: Os resultados obtidos foram satisfatórios, visto que a população se mostrou bastante interessada e participativa nos aconselhamentos, dinâmica e distribuição de materiais de apoio. Conclusão: As ações em saúde permitiram a compressão dos integrantes do PET-saúde sobre a importância da utilização de estratégias em saúde para a prevenção e promoção da saúde

Objective: to describe the activities carried out by a PET-SAÚDE tutorial group, in a Specialized Center in the city of Feira de Santana, on the prevention of breast and prostate cancer in the months of October and November 2022. Methodology: The experiences were based on verbal guidance and advice on the importance of healthy living habits, screening methods and early diagnosis. Results: The results obtained were satisfactory, since the population showed to be very interested and participatory in counseling, dynamics and distribution of support materials. Conclusion: The health actions allowed the members of the PET-health to understand the importance of using health strategies for prevention and health promotion.

Objetivo: describir las actividades realizadas por un grupo tutorial PETSAÚDE, en un Centro Especializado de la ciudad de Feira de Santana, sobre la prevención del cáncer de mama y próstata en los meses de octubre y noviembre de 2022. Metodología: Las experiencias fueron basada en orientaciones y consejos verbales sobre la importancia de hábitos de vida saludables, métodos de cribado y diagnóstico precoz. Resultados: Los resultados obtenidos fueron satisfactorios, ya que la población se mostró muy interesada y participativa en la consejería, dinámica y distribución de materiales de apoyo. Conclusión: Las acciones de salud permitieron a los integrantes del PET-salud comprender la importancia de utilizar estrategias de salud para la prevención y promoción de la salud.

Les urgences urologiques dans deux hôpitaux universitaires de Douala: une étude rétrospective (2016-2020) / Urological emergencies in two university hospitals in Douala: a retrospective study (2016-2020)

Introduction: les urgences en urologie sont des situations urologiques critiques qui nécessitent une intervention rapide par un professionnel de santé qualifié en urologie. Cette étude a été menée dans le but de ressortir le profil des urgences urologiques reçues dans deux hôpitaux universitaires de la ville de Douala en appréciant leurs prises en charge en urgence. Méthodes: il s´agit d´une étude rétrospective portant sur les urgences urologiques dans deux hôpitaux de références de la ville de Douala que sont les hôpitaux Laquintinie et Général de Douala. Les dossiers ont été colligés durant une période de 5 ans (1er janvier 2016 au 31 décembre 2020). Nous avons inclus toutes les consultations effectuées en urgence et reçues par le service des urgences ainsi que toutes les données cliniques et thérapeutiques venant du registre de garde durant la période d´étude. Nous avons exclu de notre étude toutes les urgences (consultations reçues pendant la période d´étude, non relevées dans le registre des urgences) Résultats: nous avons étudié 364 patients, l´âge moyen des patients était de 43 ± 8,34 ans. Quatre vingt-douze virgule cinquante huit pourcent (92,58%) (n=337) des patients étaient des hommes. Les principales urgences urologiques reçues étaient la rétention d´urine vésicale (45,05%, n=164), la colique néphrétique (15,33%, n=56) et l´hématurie (13,18%, n=48). Les principales étiologies des rétentions d´urine vésicale étaient les tumeurs prostatiques, la colique néphrétique était principalement d´origine lithiasique (96,45%, n=159) et l´hématurie était d´origine tumorale chez 68,75%(n=33) des patients. Sur le plan thérapeutique, les gestes effectués en urgence étaient le sondage vésical (39,01%, n=142), le traitement médical était associé à une surveillance (27,47%, n=100) et la cystostomie sus pubienne (10,71%, n=39). Conclusion: les rétentions aigues d´urines vésicales sur tumeurs prostatiques constituent l´urgence urologique la plus fréquente dans les hôpitaux universitaires de la ville de Douala. Cela implique une prise en charge précoce et optimale des tumeurs prostatiques.

Safe duration of silicon catheter replacement in urological patients

Objectives: This study compared the infection rates, degree of encrustation, symptoms, and complications in patients regarding the duration of urethral catheterisation (three weeks, six weeks, and eight weeks). Design: A cross-sectional study with stratified simple random sampling Setting: Urology Unit, Korle Bu Teaching Hospital Participants: One hundred and thirty-seven male patients with long-term urinary catheters Interventions: Participants were grouped into 3 weeks, 6 weeks, and 8 weeks duration of catheter replacementsPrimary outcomes measures: Symptoms due to the urinary catheters, urinalysis, urine and catheter tip cultures, sensitivity, and catheter encrustations were assessed. Results: Eighty-six patients had a primary diagnosis of benign prostatic hyperplasia (BPH), 35 had urethral strictures,13 had prostate cancer, two had BPH and urethral strictures, and one participant had bladder cancer. There was no difference in the symptoms the participants in the different groups experienced due to the urinary catheters (p > 0.05). The frequency of occurrence of complications (pyuria, p = 0.784; blocked catheter, p=0.097; urethral bleeding, p=0.148; epididymo-orchitis, p=0.769 and bladder spasms, p=1.000) showed no differences in the three groups. There was no statistical difference in the urinalysis for the three groups (p>0.05) and the degree of encrustations (3 weeks: 0.03 ± 0.06, 6 weeks: 0.11±0.27 and eight weeks: 0.12 ±0.27) with p=0.065. Conclusions: In this study, the duration of urinary catheterisation using silicone Foley's catheters did not influence the complication and symptom rates; hence silicon catheters can be placed in situ for up to 8 weeks before replacement instead of the traditional three-weekly change.

Factores de riesgo asociados a metástasis en pacientes con cáncer de próstata: Un estudio observacional de centro único / Risk factors associated with metastasis in patients with prostate cancer. A single-center observational study

Introducción: El cáncer de próstata (CP) el segundo cáncer diagnosticado en hombres, con mayor incidencia a los 66 años. La obesidad, el tabaquismo, alcoholismo y antecedentes familiares de CP se han encontrado asociados al riesgo de metástasis. El objetivo del presente estudio fue medir la aso-ciación entre factores y el estado metastásico en pacientes con CP en un centro único de referencia en Ecuador. Metodología: El presente estudio analítico, se realizó en el Hospital "Teodoro Maldonado Carbo", en Guayaquil-Ecuador, en el período enero-diciembre del 2019. El cálculo muestral fue no probabilístico, tipo censo. Se incluyeron casos con CP. Las variables fueron: edad, PSA, escala de Gleason, presencia de metástasis, sintomatología, tabaquismo, obesidad y antecedentes. Se presenta Odds Ratio como medida de asociación con intervalo de confianza del 95% y valor P. Resultados: El estudio incluyó 363 pacientes, con edad promedio de 75.2 ± 9.6 años. El grupo con metástasis fue de 202 casos (55.65%). Metástasis ósea 32.5%, pulmonar 9.6%, ganglionar 8.8% y hepático 4.75%. En la sintomatología la más frecuente fue, disuria (44.4%); el 33.6% con polaquiuria, un 13.2% hematuria y 8.8% tenesmo. El estadio Gleason-9 OR=24.85 (IC 95% 1.47-419.8) P=0.0259. El nivel de PSA >19 ng/ml OR= 6.996 (IC 95% 2.68-18.29) P=0.0001. El tabaquismo OR=2.34 (IC 95% 1.52-3.60) P=0.0001. Fueron factores protectores el valor de PSA <19 ng/ml OR=0.082 (IC 95% 0.043-0.157) P<0.0001, acudir a consulta de Hipertensión arterial OR=0.33 (IC 95% 0.161-0.691) P=0.0032 y el estadío Gleason-6 OR=0.108 (IC 95% 0.0665-9.1736) P<0.0001. Conclusión: Los niveles de PSA >19 ng/ml y el estadio Gleason >9 se asocian a la presencia de metástasis en pacientes con CP.

Introduction: Prostate cancer (PC) is the second most common cancer diagnosed in men, with the highest incidence at 66 years of age. Obesity, smoking, alcoholism, and a family history of PC are associated with the risk of metastasis. This study aimed to measure the association between factors and the metastatic state in patients with PC in a single reference center in Ecuador. Methodology: This analytical study was conducted at the "Teodoro Maldonado Carbo" Hospital in Guayaquil-Ecuador, January-December 2019. The sample calculation was nonprobabilistic, census type, and cases with PC were included. The variables were age, PSA, Gleason score, presence of me-tastases, symptoms, smoking, obesity, and history. The odds ratio was used to measure the associa-tion with a 95% confidence interval and P value. Results: The study included 363 patients, with a mean age of 75.2 ± 9.6 years. The group with me-tastasis included 202 patients (55.65%). Bone metastasis 32.5%, lung 9.6%, lymph nodes 8.8%, and liver 4.75%. In the symptomatology, the most frequent were dysuria (44.4%), 33.6% with pollakiuria, 13.2% hematuria, and 8.8% tenesmus. Gleason stage-9 OR=24.85 (95% CI 1.47-419.8) P=0.0259. PSA level >19 ng/ml OR= 6.996 (95% CI 2.68-18.29) P =0.0001. Smoking OR=2.34 (95% CI 1.52-3.60) P=0.0001. Protective factors were PSA value <19 ng/ml OR=0.082 (95% CI 0.043-0.157) P<0.0001, arterial hypertension consultation OR=0.33 (95% CI 0.161-0.691) P=0.0032 and stage Gleason-6 OR=0.108 (95% CI 0.0665-9.1736) P<0.0001. Conclusión: PSA levels >19 ng/ml and Gleason stage > nine are associated with metastases in patients with PC.

O impacto da pandemia da COVID-19 nos exames de rastreamento do câncer no Brasil: um estudo comparativo dos cânceres de mama, próstata e colo de útero / The impact of the COVID-19 pandemic on cancer screening tests in Brazil: a comparative study of breast, prostate, and cervical cancers

Objetivo: Analisar a influência da pandemia da COVID-19 na execução dos exames de rastreamento e diagnóstico dos cânceres de próstata, mama e colo uterino na população brasileira. Métodos: Estudo analítico transversal e quantitativo com levantamento do número desses exames realizados pelo SUS (Sistema Único de Saúde). Os dados foram extraídos do Datasus nos períodos de pré-pandemia (março/2019 a fevereiro/2020) e pandemia (março/2020 a fevereiro/2021). Foram extraídos os números de exames realizados mês a mês e comparados os períodos pré-pandemia com o de pandemia. Foi realizada uma análise estatística descritiva, e as médias mensais de exames realizados nos dois períodos foram comparadas usando o teste t de Student. Resultados: Na comparação entre os períodos pré-pandemia e de pandemia, houve diminuição de média de 45,2% no número de exames citopatológicos, (194.978 exames por mês a menos; p < 0,00001), de 44,4% nos exames de mamografia (142.015 mamografias a menos por mês; p < 0,00001) e de 24,4% nos exames de antígeno prostático específico (PSA) (148.815 exames a menos por mês; p = 0,0012). Conclusão: A influência da pandemia gerou uma diminuição considerável no número de exames de rastreamento, mamografia, dosagem de PSA e citopatológico, o que deverá se traduzir em aumento nos casos de doença avançada, com graves consequências negativas para os pacientes e para o sistema de saúde.

Objective: To analyze the impact of COVID-19 pandemic on the number of screening and diagnostic cancer tests performed for prostate, breast and cervical cancer in the Brazilian population. Methods: This was a transversal analytical and quantitative study on the number of screening and diagnostic cancer tests performed in the public Brazilian health care system SUS (Sistema Único de Saúde). Data were collected from the Datasus (online SUS database) during pre-pandemic (March/2019 to February/2020) and pandemic periods (March/2020 to February/2021). We obtained the number of tests performed monthly for each of the tests and compared the two periods. Descriptive statistics were employed and the monthly average number of tests performed in each period were compared using the T Student test. Results: Comparing the pre-pandemic levels with pandemic levels, we found that there was a 45.2% decrease in the number of Papanicolaou (PAP smear) tests (194,978 less exams per month, p < 0,00001), 44.4% decrease in mammograms (142,015 less tests per month, p < 0,00001), and a reduction of 24.4% in the number of prostate specific antigen (PSA) tests per month (minus 148,815 exams performed, p < 0.0012). Conclusion: There was a statistically significant reduction in the number of screening/diagnostic mammograms, PAP smears and PSA performed during the pandemic period, compared to the period before COVID-19. This reduction may result in an increase in the number of cases diagnosed at an advanced stage, with grave consequences for the patients and for the sustainability of the healthcare system.

Efeito do oncofitness na amplitude articular de pacientes com câncer de próstata / Efecto del oncofitnessen el rango de movimiento articular de pacientes con cáncer de próstata / Effect of oncofitness in joint amplitude of patients with prostate cancer

RESUMO O objetivo da pesquisa foi avaliar o efeito de um Programa de Exercício Físico Oncológico - ONCOFITNESS na amplitude articular em pacientes com câncer submetidos à radioterapia. O estudo é um tipo de ensaio clínico prospectivo randomizado controlado no qual se compara o efeito e o valor de uma intervenção, com características profiláticas ou terapêuticas, em seres humanos. Os procedimentos consideraram as normas para realização de pesquisas em seres humanos com a aprovação do projeto pelo CEP/Hospital Mário Kröeff. A avaliação da flexibilidade foi realizada seguindo o protocolo LABIFIE, com goniômetro de aço da marca Lafayette® (EUA). O grupo experimental realizou uma intervenção com Oncofitness. Após esse período, foi realizada outra avaliação, seguindo os mesmos procedimentos. A análise estatística foi realizada no programa SPSS (Statistical Package for the Social Sciences) versão 20.0. A amostra foi composta por 30 homens com idade GE (X ̅ = 59,0 ± 2,0 anos) e GC (X ̅ = 60,0 ± 1,0 anos). Os dados revelaram que os ganhos do GE foram observados em: flexão do joelho (∆%=5,0%, p=0,0011x); em abdução do quadril (∆%=15,8%, p=0,003x); em rotação interna (∆%=8,1%, p=0,0129x) e em flexão de ombro, (∆%=8,3%, p=0,0185x). Não foi observado ganho no GC, pode-se verificar que o Oncofitness proporcionou a redução de alguns dos sintomas relacionados aos tratamentos oncológicos devido à melhora da amplitude articular.

RESUMEN El objetivo de la investigación fue evaluar el efecto de un Programa de Ejercicios Físicos Oncológicos - ONCOFITNESS en la amplitud articular en pacientes oncológicos sometidos a radioterapia. El estudio es tipo ensayo clínico controlado randomizado, prospectivo en que compara el efecto y valor de una intervención, con características profilácticas o terapéuticas, en seres humanos. Los procedimientos consideraron las normas para la realización de investigación en seres humanos con la aprobación del proyecto por el CEP/Hospital Mário Kröeff. La evaluación de la flexibilidad fue realizada siguiendo el protocolo del LABIFIE, con un goniómetro de acero da marca Lafayette® (EUA). El grupo experimental realizó una intervención con el Oncofitness. Después de ese periodo, se realizó otra evaluación, siguiendo los mismos procedimientos. El análisis estadístico fue realizado mediante el SPSS (Statistical Package for the Social Sciences) versión 20.0. La muestra fue de 30 hombres con edades GE (X ̅ = 59,0 ± 2,0 años) y GC (X ̅ = 60,0 ± 1,0 años). Los datos revelaron que fueron observadas ganancias GE en: flexión de rodillas (∆%=5,0%, p=0,0011x); en la abducción de cadera (∆%=15,8%, p=0,003x); en la rotación interna (∆%=8,1%, p=0,0129x) y en flexión de hombro, (∆%=8,3%, p=0,0185x). No fue observada ganancia en el GC, se puede verificar que el Oncofitness proporcionó la reducción de algunos de los síntomas relacionados a los tratamientos oncológicos por la mejora de la amplitud articular.

ABSTRACT The research aimed to evaluate the effect of an Oncology Physical Exercises Program - ONCOFITNESS on the joint range of cancer patients undergoing radiotherapy. The study is considered a randomized controlled clinical trial, being prospective in that it compares the effect and value of an intervention, with prophylactic or therapeutic characteristics, in human beings. The procedures met the standards for researching human beings, and the project was approved. CEP/Hospital Mário Kröeff. Flexibility measurement performed following the LABIFIE protocol, with a Lafayette® brand steel goniometer (USA). The experimental group performed an intervention with Oncofitness. After this period, another evaluation was carried out, following the same procedures. Statistical analysis was performed using SPSS (Statistical Package for the Social Sciences) version 20.0. Sample of 30 men aged GE (X ̅ = 59.0 ± 2.0 years) and CG (X ̅ = 60.0 ± 1.0 years). The data revealed that gains were observed in the EG in knee flexion (∆%=5.0%, p=0.0011x); in hip abduction (∆%=15.8%, p=0.003x); in internal rotation (∆%=8.1%, p=0.0129x) and in shoulder flexion, (∆%=8.3%, p=0.0185x). As was not observed in the CG, Oncofitness provided a reduction in some of the symptoms related to oncological treatments by improving joint range of motion.

Correlación entre las pruebas de antígeno prostático específico rápida y sérica / Correlation between rapid and serum prostate-specific antigen tests

Introducción: Al día de hoy no se ha alcanzado un consenso sobre el mejor enfoque para realizar el tamizaje y la detección precoz del Cáncer de Próstata (CaP), en la población. No obstante, hay programas que recomiendan la utilización de la prueba de antígeno prostático específico rápida para la detección de CaP sin un análisis de correlación frente a la prueba sérica. Objetivo: Identificar la correlación entre las pruebas de antígeno prostático específico rápida y sérica, en la población mexicana. Métodos: Se realizó un estudio descriptivo, transversal y retrospectivo, bajo un muestreo no probabilístico por conveniencia. En el período comprendido entre el 25 de mayo al 13 de julio de 2017. Se calcularon los coeficientes de correlación punto biserial (r pb ) y phi (r phi ). Resultados: Se incluyeron 1 635 registros, principalmente de la Ciudad de México y del Estado de México (n= 1 398; 85,5 por ciento, IC95 por ciento 81-89,9). La edad promedio fue de 51 años (DE= 7,68). El valor promedio de antígeno prostático sérico fue de 1,49 ng/mL (DE= 1,91). La proporción de hombres con una prueba rápida positiva (n=60; 3,7 por ciento; IC95 por ciento 2,9-4,6) fue menor (p= 0,0415) en comparación con la proporción de pacientes con una prueba sérica ≥ 4 ng/mL (n=85; 5,2 por ciento; IC95 por ciento 4,1-6,3). El número de casos dobles negativos fue de 1 530 (93,6 por ciento; IC95 por ciento 92,3-94,6) y de dobles positivos fue de 40 (2,4 por ciento; IC95 por ciento1,7-3,2). Los coeficientes de correlación punto biserial y phi mostraron una correlación baja entre la prueba rápida y la prueba sérica de antígeno prostático (rpb= 0,469; p < 0,001; r2= 0,2199 y r ph i= 0,540; p < 0,001; r2= 0,2916). Conclusiones: La prueba de antígeno prostático específico rápida es una herramienta conveniente para los programas de detección de alteración prostática en unidades médicas del primer nivel de atención, donde la prueba sérica no se puede realizar, al ser una prueba con una baja sensibilidad y con un bajo coeficiente de correlación respecto de la prueba de antígeno prostático específico sérica, esto es un punto importante que debe considerarse al diseñar programas de detección oportuna de cáncer de próstata(AU)

Introduction: To date, no consensus has been reached on the best approach for screening and early detection of Prostate Cancer (PCa) in the population. However, there are programs recommending the use of the rapid prostate-specific antigen test for the detection of PCa without a correlation analysis versus the serum test. Objective: To identify the correlation between rapid and serum prostate specific antigen tests in the Mexican population. Methods: A descriptive, cross-sectional and retrospective study was carried out, under a non-probabilistic convenience sampling from May 25 to July 13, 2017. The correlation coefficients of point biserial (rpb) and phi (rphi) were calculated. Results: One thousand six hundred thirty five (1,635) records were included, mainly from Mexico City and the State of Mexico (n= 1,398; 85.5 percent, 95 percent CI 81-89.9). The average age was 51 years (SD= 7.68). The mean value of serum prostate antigen was 1.49 ng/ml (SD= 1.91). The proportion of men with positive rapid test (n=60; 3.7 percent; 95 percent CI 2.9-4.6) was lower (p= 0.0415) compared to the proportion of patients with a serum test ≥ 4 ng/ml (n= 85; 5.2 percent; 95 percent CI 4.1-6.3). The number of double negative cases was 1,530 (93.6 percent; CI95 percent 92.3-94.6) and of double positives was 40 (2.4 percent; CI95 percent 1.7-3.2). The point biserial and phi correlation coefficients showed low correlation between the rapid test and the serum prostate antigen test (rpb= 0.469; p < 0.001; r2= 0.2199 and rphi= 0.540; p < 0.001; r2= 0. 2916). Conclusions: The rapid prostate-specific antigen test is a convenient tool for prostatic alteration detection programs in primary care medical units, where the serum test cannot be performed, however, as it is a test with low sensitivity and with low correlation coefficient with respect to serum prostate-specific antigen testing, this is an important point to consider when designing prostate cancer early detection programs(AU)

Nerve-sparing robotic-assisted radical prostatectomy: how I do it after 15. 000 cases

ABSTRACT Introduction: Over the years, since Binder and Kramer described the first Robotic-assisted Radical Prostatectomy (RARP) in 2000, different Nerve-sparing (NS) techniques have been proposed by several authors (1). However, even with the robotic surgery advantages, functional outcomes following RARP, especially erection recovery, still challenge surgeons and patients (2, 3). In this scenario, we have described different ways and grades of neurovascular bundle preservation (NVB) using the prostatic artery as a landmark until our most recent technique with lateral prostatic fascia preservation and modified apical dissection (4-6). In this video compilation, we have illustrated the anatomical and technical details of different grades of NVB preservation. Surgical technique: After the anterior and posterior bladder neck dissection, we lift the prostate by the seminal vesicles to access the posterior aspect of the prostate. Then, we incise the Denonvilliers layers and work between an avascular plane to release the posterior NVB from 5 to 1 and 7 to 11 o'clock positions on the right and left sides, respectively6. In sequence, we access the prostate anteriorly by incising the endopelvic fascia bilaterally (close to the prostate) until communicating the anterior and posterior planes. Finally, we control the prostatic pedicles with Hem-o-lok clips and then proceed for the apical dissection preserving the maximum amount of urethra length and periurethral tissues. Considerations: Potency recovery following radical prostatectomy remains a challenge due to its multifactorial etiology. However, basic concepts for nerve-sparing are crucial to achieving optimal outcomes, such as minimizing the amount of traction used on dissection, avoiding excessive cautery, and neural preservation based on anatomical landmarks (arteries and planes of dissection).

Neurovascular bundle preservation in robotic-assisted radical prostatectomy: How I do it after 15. 000 cases

ABSTRACT Despite the neuroanatomy knowledge of the prostate described initially in the 1980's and the robotic surgery advantages in terms of operative view magnification, potency outcomes following robotic-assisted radical prostatectomy still challenge surgeons and patients due to its multifactorial etiology. Recent studies performed in our center have described that, in addition to the surgical technique, some important factors are associated with erectile dysfunction (ED) following robotic-assisted radical prostatectomy (RARP). These include preoperative Sexual Health Inventory for Men (SHIM) score, age, preoperative Gleason score, and Charlson Comorbidity Index (CCI). After performing 15,000 cases, in this article we described our current Robotic-assisted Radical Prostatectomy technique with details and considerations regarding the optimal approach to neurovascular bundle preservation.

Impact of lifestyle in prostate cancer patients. What should we do?

ABSTRACT Objective: This review aimed to analyze interventions raised within primary and tertiary prevention concerning the disease's incidence, progression, and recurrence of Prostate Cancer (PCa). Priority was given to the multidisciplinary approach of PCa patients with an emphasis on modifiable risk factors. Materials and Methods: We conducted a comprehensive literature review in the following databases: Embase, Central, and Medline. We included the most recent evidence assessing cohort studies, case-control studies, clinical trials, and systematic reviews published in the last five years. We only included studies in adults and in vitro or cell culture studies. The review was limited to English and Spanish articles. Results: Preventive interventions at all levels are the cornerstone of adherence to disease treatment and progression avoidance. The relationship in terms of healthy lifestyles is related to greater survival. The risk of developing cancer is associated to different eating habits, determined by geographic variations, possibly related to different genetic susceptibilities. Discussion: PCa is the second most common cancer in men, representing a leading cause of death among men in Latin America. Prevention strategies and healthy lifestyles are associated with higher survival rates in PCa patients. Also, screening for anxiety and the presence of symptoms related to mood disorders is essential in the patient's follow-up concerning their perception of the condition.

Available evidence on HIFU for focal treatment of prostate cancer: a systematic review

ABSTRACT Purpose: Prostate cancer (PCa) is the second most common oncologic disease among men. Radical treatment with curative intent provides good oncological results for PCa survivors, although definitive therapy is associated with significant number of serious side-effects. In modern-era of medicine tissue-sparing techniques, such as focal HIFU, have been proposed for PCa patients in order to provide cancer control equivalent to the standard-of-care procedures while reducing morbidities and complications. The aim of this systematic review was to summarise the available evidence about focal HIFU therapy as a primary treatment for localized PCa. Material and methods: We conducted a comprehensive literature review of focal HIFU therapy in the MEDLINE database (PROSPERO: CRD42021235581). Articles published in the English language between 2010 and 2020 with more than 50 patients were included. Results: Clinically significant in-field recurrence and out-of-field progression were detected to 22% and 29% PCa patients, respectively. Higher ISUP grade group, more positive cores at biopsy and bilateral disease were identified as the main risk factors for disease recurrence. The most common strategy for recurrence management was definitive therapy. Six months after focal HIFU therapy 98% of patients were totally continent and 80% of patients retained sufficient erections for sexual intercourse. The majority of complications presented in the early postoperative period and were classified as low-grade. Conclusions: This review highlights that focal HIFU therapy appears to be a safe procedure, while short-term cancer control rate is encouraging. Though, second-line treatment or active surveillance seems to be necessary in a significant number of patients.

Association between fecal incontinence and lower urinary tract symptoms and their impact on the quality of life of patients with prostate cancer

Objective: To evaluate the association of fecal incontinence (FI) and lower urinary tract symptoms (LUTS) in patients diagnosed with initial prostate cancer (PC) and after any therapeutic approach (surgery and radiotherapy). Methods: Cross-sectional study using the Cleveland Clinic Incontinence Score (CCIS), the Fecal Incontinence Quality of Life (FIQL) questionnaire, and the International Consultation on Incontinence Questionnaire Overactive Bladder (ICIQ-OAB). Results: A total of 84 patients with PC were included: 40 of them had not started treatment, 31 were submitted to radical prostatectomy (RP), and 13 were submitted to radiotherapy (RT). Those submitted to RT presented higher scores on the ICIQ-OAB (p=0.01). When comparing the whole sample reagarding the patients with and without FI, we observed that the incontinents presented a higher frequency of urinary incontinence (UI) (p<0.001). Moreover, when comparing patients with/without FI within their treatment groups regarding the presence of UI and FIQL scores, we identified that patients undergoing RP presented an association between UI and FI (p<0.001) and a greater impact of FI on the FIQL (p<0.001). Conclusion: Patients submitted to RT present more intense LUTS. Moreover, patients with FI present a higher association with UI, and this association is more marked in those with FI submitted to RP. (AU)

Tamización del cáncer de próstata en Colombia: ¿Es posible superar la controversia? / Prostate Cancer Screening in Colombia: ¿Is It Possible to Overcome the Controversy?

La detección temprana sigue siendo pilar fundamental en el control del cáncer ya que no mas de 30% de las neoplasias malignas se pueden prevenir mediante la intervención de sus factores de riesgo,[1] y adicionalmente, la enfermedad localizada sigue teniendo mayor supervivencia que los estados metastásicos, aún con la sustancial mejora del tratamiento sistémico. A pesar de ello, existe una controversia creciente acerca de la tamización, en donde juega papel central el sobrediagnóstico. La reducción de la mortalidad es el objetivo primordial de la tamización en cáncer y dada la frecuente manifestación tardía de síntomas, la búsqueda de la enfermedad en población asintomática reviste toda lógica; no obstante, esta lógica se basa en la definición de neoplasia maligna como el crecimiento anómalo de células con capacidad de invasión progresiva, capacidad que se determina por cambios morfológicos y no por la dinámica de la enfermedad. Hoy se sabe que los cambios morfológicos tienen espectro amplio con cursos naturales variables, incluyendo neoplasias que no progresan o que progresan muy lentamente sin que lleguen a manifestarse durante la vida del paciente.

Early detection remains a fundamental pillar in cancer control since no more than 30% of malignant neoplasms can be prevented by intervention of their risk factors,[1] and additionally, localized disease continues to have longer survival than metastatic stages, even with the substantial improvement in systemic treatment. Despite this, there is a growing controversy about screening, in which overdiagnosis plays a central role. The reduction of mortality is the primary objective of cancer screening and given the frequent late manifestation of symptoms, the search for the disease in an asymptomatic population is logical; however, this logic is based on the definition of malignant neoplasm as the abnormal growth of cells with progressive invasive capacity, a capacity that is determined by morphologic changes and not by the dynamics of the disease. It is now known that morphologic changes have a broad spectrum with variable natural courses, including neoplasms that do not progress or that progress very slowly without ever manifesting themselves during the patient's lifetime.

Câncer de próstata em trabalhadores rurais expostos a agrotóxicos: revisão de escopo / Prostate cancer in rural workers exposed to agrochemicals: scope review

Desde o início dos anos 2000 é crescente o número de estudos que avaliam a exposição a agrotóxicos e suas consequências para a saúde do trabalhador. Contudo, não há sistematização da produção relacionada ao câncer de próstata em trabalhadores rurais. Assim, objetivou-se mapear a literatura que trata da associação entre a exposição aos agrotóxicos e a ocorrência de câncer de próstata em trabalhadores rurais. Foi realizada uma revisão de escopo nas bases de dados Web of Science (WoS), Scopus, Cumulative Index to Nursing and Allied Health Literature (CINHAL) e Biblioteca Virtual em Saúde (BVS), empregando os descritores "Agrochemicals", "Farmers" e "Prostatic Neoplasms". Dezenove artigos fizeram parte desta revisão. Em dezessete, verificou-se associações entre a ocorrência de câncer de próstata em trabalhadores rurais e a exposição a agrotóxicos. Os fatores de risco relacionados foram: histórico familiar, tabagismo, raça/cor, idade avançada, alterações genéticas, toneladas de soja produzidas e o uso de agrotóxicos específicos. A literatura aponta a existência de consistência e plausibilidade biológica para a ocorrência de câncer de próstata em indivíduos expostos a agrotóxicos que exercem atividades agrícolas.

Since the early 2000s there has been an increasing number of studies evaluating pesticide exposure and its consequences for worker health. However, they are not systematized in relation to prostate cancer in rural workers. We aimed to map the literature dealing with the association between exposure to pesticides and the occurrence of prostate cancer in rural workers. A scoping review was conducted in the Web of Science (WoS), Scopus, Cumulative Index to Nursing and Allied Health Abstract Literature (CINHAL) and Virtual Health Library (VHL) databases. The descriptors "Agrochemicals", "Farmers" and "Prostatic Neoplasms" were employed. Nineteen articles were part of this review. In seventeen articles, associations were found between the occurrence of prostate cancer in rural workers and exposure to agrochemicals. The related risk factors were: family history, smoking, race/color, advanced age, genetic alterations, tons of soybeans produced, and the use of specific pesticides. The literature points to the existence of consistency and biological plausibility for the occurrence of prostate cancer in individuals exposed to pesticides who perform agricultural activities.

Should obesity be associated with worse urinary continence outcomes after robotic-assisted radical prostatectomy? a propensity score matching analysis

ABSTRACT Purpose: To analyze the association between obesity and urinary incontinence rate in men submitted to robot-assisted radical prostatectomy (RARP) in a high-volume cancer center. Materials and Methods: We reported 1.077 men who underwent RARP as the primary treatment for localized prostate cancer from 2013 to 2017. Patients were classified as non-obese (normal BMI or overweight) or obese men (BMI ≥30kg/m2). They were grouped according to the age, PSA level, D'Amico risk group, Gleason score, ASA classification, pathological stage, prostate volume, salvage/adjuvant radiotherapy, perioperative complications, and follow-up time. Urinary continence was defined as the use of no pads. For the analysis of long-term urinary continence recovery, we conducted a 1:1 propensity-score matching to control confounders. Results: Among the obese patients, mean BMI was 32.8kg/m2, ranging 30 - 45.7kg/m2. Only 2% was morbidly obese. Obese presented more comorbidities and larger prostates. Median follow-up time was 15 months for the obese. Complications classified as Clavien ≥3 were reported in 5.6% of the obese and in 4.4% of the non-obese men (p=0.423). Median time for continence recovery was 4 months in both groups. In this analysis, HR was 0.989 for urinary continence recovery in obese (95%CI=0.789 - 1.240; p=0.927). Conclusions: Obese can safely undergo RARP with similar continence outcomes comparing to the non-obese men when performed by surgeons with a standardized operative technique. Future studies should perform a subgroup analysis regarding the association of obesity with other comorbidities, intending to optimize patient counseling.